Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Enalapril Maleate
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Approved FDF
Sponsor : Azurity Pharma
Deal Size : Undisclosed
Deal Type : Acquisition
Azurity Pharmaceuticals to Acquire and Merge with Arbor Pharmaceuticals
Details : The combined company, operating as Azurity, will have a portfolio of products serving the unmet needs of patients in the cardiovascular, central nervous system, endocrinological, gastrointestinal, and institutional markets with many products like Epaned.
Product Name : Epaned
Product Type : Miscellaneous
Upfront Cash : Undisclosed
August 24, 2021
Lead Product(s) : Enalapril Maleate
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Approved FDF
Sponsor : Azurity Pharma
Deal Size : Undisclosed
Deal Type : Acquisition
Lead Product(s) : Enalapril Maleate
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Phase III
Sponsor : National Clinical Research Center, Southern Medical University | Ningbo Yinzhou Community Health Service Center
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Enalapril is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Hypertension.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
July 07, 2021
Lead Product(s) : Enalapril Maleate
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Phase III
Sponsor : National Clinical Research Center, Southern Medical University | Ningbo Yinzhou Community Health Service Center
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Enalapril Maleate
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Phase II/ Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Enalapril is a Other Small Molecule drug candidate, which is currently being evaluated in phase II/ phase III clinical studies for the treatment of Heart Failure.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
January 13, 2016
Lead Product(s) : Enalapril Maleate
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Phase II/ Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Enalapril Maleate
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Phase II/ Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Orodispersible Minitablets of Enalapril in Children With Heart Failure Due to Dilated Cardiomyopathy
Details : Enalapril is a Other Small Molecule drug candidate, which is currently being evaluated in phase II/ phase III clinical studies for the treatment of Heart Failure.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
January 12, 2016
Lead Product(s) : Enalapril Maleate
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Phase II/ Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Enalapril Maleate
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Phase II/ Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Enalapril is a Other Small Molecule drug candidate, which is currently being evaluated in phase II/ phase III clinical studies for the treatment of Heart Failure.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
January 12, 2016
Lead Product(s) : Enalapril Maleate
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Phase II/ Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Enalapril Maleate
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Phase I
Sponsor : European Commission
Deal Size : Inapplicable
Deal Type : Inapplicable
Relative Bioavailability Study With Enalapril in Healthy Volunteers
Details : Enalapril is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Heart Failure.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
September 30, 2014
Lead Product(s) : Enalapril Maleate
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Phase I
Sponsor : European Commission
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Enalapril Maleate
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Phase IV
Sponsor : ZonMw
Deal Size : Inapplicable
Deal Type : Inapplicable
Treatment of HYpertension: Morning Versus Evening
Details : Enalapril is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Essential Hypertension.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
August 12, 2014
Lead Product(s) : Enalapril Maleate
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Phase IV
Sponsor : ZonMw
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Enalapril Maleate
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Phase IV
Sponsor : Nanfang Hospital, Southern Medical University
Deal Size : Inapplicable
Deal Type : Inapplicable
CSPPT- Chronic Kidney Diseases Study
Details : Enalapril Maleate is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Hypertension.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
June 07, 2013
Lead Product(s) : Enalapril Maleate
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Phase IV
Sponsor : Nanfang Hospital, Southern Medical University
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Enalapril Maleate
Therapeutic Area : Nephrology
Study Phase : Phase I/ Phase II
Sponsor : World Health Organization
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Enalapril is a Other Small Molecule drug candidate, which is currently being evaluated in phase I/ phase II clinical studies for the treatment of Renal Insufficiency, Chronic.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
June 20, 2012
Lead Product(s) : Enalapril Maleate
Therapeutic Area : Nephrology
Highest Development Status : Phase I/ Phase II
Sponsor : World Health Organization
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Enalapril Maleate
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Phase III
Sponsor : Servier | LivaNova
Deal Size : Inapplicable
Deal Type : Inapplicable
Is There a Benefit to Optimize Heart Failure (HF) Treatment in Aged Over 80 Year's Old Patients?
Details : Enalapril is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Heart Failure.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
September 20, 2011
Lead Product(s) : Enalapril Maleate
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Phase III
Sponsor : Servier | LivaNova
Deal Size : Inapplicable
Deal Type : Inapplicable